Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Tarney

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
JCO Precision Oncology|May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer RecurrenceJesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
Scientific Reports|May 1, 2021
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patientsNicholas W Bateman, Christopher M Tarney, Tamara Abulez, et al.
Gynecologic Oncology|August 28, 2023
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
JAMA Network Open|April 17, 2023
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine CancerCalen W Kucera, Chunqiao Tian, Christopher M Tarney, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Gynecologic Oncology|February 10, 2024
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factorsCalen W Kucera, Nicole P Chappell, Chunqiao Tian, et al.
Gynecologic Oncology|January 26, 2024
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypesStuart S Winkler, Chunqiao Tian, Yovanni Casablanca, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
JCO Precision Oncology|May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer RecurrenceJesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
Scientific Reports|May 1, 2021
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patientsNicholas W Bateman, Christopher M Tarney, Tamara Abulez, et al.
Gynecologic Oncology|August 28, 2023
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatmentWei Ao, Hong Im Kim, Domenic Tommarello, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Clinical Proteomics|October 6, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancersChristopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
JAMA Network Open|April 17, 2023
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine CancerCalen W Kucera, Chunqiao Tian, Christopher M Tarney, et al.
Iscience|March 5, 2024
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic dataPang-Ning Teng, Joshua P Schaaf, Tamara Abulez, et al.
Gynecologic Oncology|February 10, 2024
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factorsCalen W Kucera, Nicole P Chappell, Chunqiao Tian, et al.
Gynecologic Oncology|January 26, 2024
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypesStuart S Winkler, Chunqiao Tian, Yovanni Casablanca, et al.
Pageof 4